Bay Street News, December 6th, 2018

Proofpoint evaluated based on completeness of vision and ability to execute SUNNYVALE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) — Proofpoint, […]

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of […]

VANCOUVER, B.C., Dec. 06, 2018 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is […]

Updated Phase 2 Results in Metastatic Triple-Negative Breast Cancer to be Presented at The 2018 San Antonio Breast Cancer Symposium […]

— Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome […]

PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) — Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that […]

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — (NYSE: AFT) – Apollo Senior Floating Rate Fund Inc. (the “Fund”) today […]

ROCKVILLE, Md., Dec. 06, 2018 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing […]

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — (NYSE: AIF) – Apollo Tactical Income Fund Inc. (the “Fund”) today announced […]

FALLS CHURCH, Va., Dec. 06, 2018 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) announced today that its board of […]